Dr. Yogesh Vaishnav
Associate Professor
Work Experience
13 Years
Area of Specialization
Drug design and synthesis
Projects & Patents
NA
Education
M.Pharm., Ph.D (Pharmaceutical Chemistry)
Achievments/Awards/Honors
Best paper presentation award at School of studies in biotechnology, Pt. Ravishankar Shukla University, Raipur
Publications
1. Verma, S. K., Verma, R., Verma, S., Vaishnav, Y., Tiwari, S. P., & Rakesh, K. P. (2021). Anti-tuberculosis activity and its structure-activity relationship (SAR) studies of oxadiazole derivatives: A key review. European journal of medicinal chemistry, 209, 112886.(Impact Factor 7.1) 2. Verma SK, Verma R, Girish YR, Xue F, Yan L, Verma S, Singh M, Vaishnav Y, Shaik AB, Bhandare RR, Rakesh KP. Heterogeneous graphitic carbon nitrides in visible-light-initiated organic transformations. Green Chemistry. 2022;24(2):438-79. .(Impact Factor 11.03) 3. Bhandare, R. R., Munikrishnappa, C. S., Kumar, G. S., Konidala, S. K., Sigalapalli, D. K., Vaishnav, Y., ... & Shaik, A. B. (2022). Multistep synthesis and screening of heterocyclic tetrads containing furan, pyrazoline, thiazole and triazole (or oxadiazole) as antimicrobial and anticancer agents. Journal of Saudi Chemical Society, 26(3), 101447. .(Impact Factor 4.9) 4. A review on drug designing, methods, its application and prospects 5. Verma, R., Verma, S. K., Verma, V., Verma, S., Vaishnav, Y., Jena, V., ... & Rakesh, K. P. (2021). Catalytic pyrolysis of ulva lactuca macroalgae: Effects of mono and bimetallic catalysts and reaction parameters on bio-oil up-gradation. Bioresource Technology, 324, 124594. .(Impact Factor 11.88) 6. Vaishnav, Y., Dewangan, D., Verma, S., Mishra, A., Thakur, A. S., Kashyap, P., & Verma, S. K. (2020). PPAR gamma targeted molecular docking and synthesis of some new amide and urea substituted 1, 3, 4‐thiadiazole derivative as antidiabetic compound. Journal of Heterocyclic Chemistry, 57(5), 2213-2224. .(Impact Factor 2.1) 7. Verma Shekhar, Vaishnav Yogesh, Verma K. Santosh and Jha K. Arvind, Anhydrous Nanoemulsion: An Advanced Drug Delivery System for Poorly Aqueous Soluble Drugs, Current Nanomedicine 2017; 7(1) . https://dx.doi.org/10.2174/2468187306666160926124713 8. Thakur, D. S., Rajak, H., Kumar, P., & Vaishnav, Y. (2011). Synthesis of some novel 4-(4-chlorophenyl)-6-p-tolyl" pyrimidine derivatives and their anticonvulsant activity. Acta Pol Pharm, 68(6), 993-97. .(Impact Factor 0.4) 9. Dewangan, D., Vaishnav, Y., Mishra, A., Jha, A. K., Verma, S., & Badwaik, H. (2021). Synthesis, molecular docking, and biological evaluation of Schiff base hybrids of 1, 2, 4-triazole-pyridine as dihydrofolate reductase inhibitors. Current Research in Pharmacology and Drug Discovery, 2, 100024.(Scopus) 10. Vaishnav, Y., Thakur, A., Kaur, C. D., Verma, S., Mishra, A., Jain, S. K., & Ghode, P. (2018). QSAR Analysis of some N, N-diphenyl urea derivatives as CCR5 Receptor Antagonist. Research Journal of Pharmacy and Technology, 11(9), 3802-3810. .(Scopus) 11. Vaishnav, Y., Jha, A. K., Verma, S., Kashyap, P., & Kaur, C. D. (2017). A Review on Antidiabetic Activity of Substituted 1, 3, 4-Thiadiazole Derivatives. Research Journal of Pharmacy and Technology, 10(12), 4467-4470. .(Scopus) 12. Vaishnav Yogesh, Kashyap Pranita and Kaur Deep Chanchal, 3D QSAR Analysis on 2piperidinopiperidinethiadiazole Derivatives as Histamine H3 Receptor Inhibitors, Current Nanomedicine 2017; 7(1) . https://dx.doi.org/10.2174/2468187306666161025112622 .(Scopus) 13. Gunjan Kalyani, Y Vaishnav, S Deshmukh, R Sahu, Stability indicating method development and validation of candesartan in bulk and pharmaceutical dosage form by derivative spectrophotometric method. .(UGC) 14. Singh, P., Vaishnav, Y., & Verma, S. (2023). Development of pharmacovigilance system in India and paradigm of pharmacovigilance research: an overview. Current Drug Safety, 18(4), 448-464. (Scopus) 15. Rajni Yadav, Yogesh Vaishnav, Arvinder Kaur, Kavya Manjunath, Ashish Pandey, Point of Care diagnostics-Using Nanomaterials as detection probes.(Scopus) 16. Verma, S. K., Verma, R., Girish, Y. R., Verma, S., Pramoda, K., Vaishnav, Y., ... & Kumar, K. S. S. (2023). Two-dimensional Ti3C2Tx MXenes as a catalyst support for the synthesis of 1, 4-disubstituted-1, 2, 3-triazoles via azide-nitroalkene oxidative cycloaddition. Journal of Molecular Structure, 1281, 135145.(Impact Factor 3.8) 17. Verma, S. K., Verma, R., Girish, Y. R., Verma, S., Pramoda, K., Vaishnav, Y., ... & Kumar, K. S. S. (2023). Two-dimensional Ti3C2Tx MXenes as a catalyst support for the synthesis of 1, 4-disubstituted-1, 2, 3-triazoles via azide-nitroalkene oxidative cycloaddition. Journal of Molecular Structure, 1281, 135145. 18. Pandit, B., Vaishnav, Y., Bahadur, S., & Satapathy, T. (2023). 2D & 3D-QSAR Studies on a Series of Quinoline-Amino-piperidine Derivatives as Potent Mycobacterium DNA-Gyrase-B Inhibitors. International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN), 16(3), 6512-6521.(Scopus) 19. VS Verma, HR Badwaik, Y Vaishnav, A Alexander - Indian Journal of Pharmaceutical Sciences, Synthesis, Characterization, Molecular Modelling and Biological Evaluation of Substituted Benzo (h) Chromene-3-Carboxylate Derivatives as a Potential Agent for the Treatment of Hyperlipidemia. 84, 2;2022 (Impact Factor 0.9) 20. Vaishnav, Y., Banjare, L., Verma, S., Sharma, G., Biswas, D., Tripathi, A., ... & Manjunath, K. (2022). Computational Method on Hydroxychloroquine and Azithromycin for SARS-CoV-2: Binding Affinity Studies. Research Journal of Pharmacy and Technology, 15(12), 5467-5472. (Scopus) 21. Mishra, A., Vaishnav, Y., Jha, A. K., & Verma, S. (2021). 3D QSAR analysis on quinoxaline derivatives as anti-malarial using K-nearest neighbour molecular field analysis. Indian Journal of Chemistry-Section B (IJC-B), 60(5), 727-731.(Scopus) 22. Vaishnav Yogesh, Kashyap Pranita and Kaur Deep Chanchal, An approach to design potent anti diabetic agents by 3D QSAR studies on substituted thiadiazole derivatives using kNN-MFA methodology, Indian Journal of heterocyclic chemistry, 185-194 (Impact Factor 0.5) 23. Gunjan Kalyani, Y Vaishnav, S Deshmukh, Analytical method development and validation for the estimation of candesartan by derivative spectroscopy (first order and second order), International journal of pharmaceutical sciences and research. 24. Banjare Laxmi, Vaishnav Yogesh,Synthesis and biological evaluation of 3-chloro 2- methyl phenyl carbamoyl substituted semicarbazone derivatives as potential anticonvulsant agents, International journal of Pharma sciences and research (IJPSR), 3, 226-240 25. Arpan Kumar Tripathi, Yogesh Vaishnav, Isha sonker, Khemkaran Ahirwar, Ashish Kumar Pandey, Shekhar Verma, 2021. Formulation and In-vitro evaluation of electrolyte effervescent tablet. J. Med. P’ceutical Allied Sci. V 11 - I 1, Pages - 4465 - 4469. doi: 10.22270/jmpas.V11I1.2303. .(Scopus)